Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Alignment Healthcare

Citadel's Ken Griffin Invests $124M in Medicare Advantage Firm Days Before Its Victory in Ratings Case

Citadel Advisor's Ken Griffin bought over 9.1 million shares of the Alignment Healthcare stock days before the tech-enabled Medicare Advantage company announced a partial victory in a legal battle against the Centers for Medicare and Medicaid Services.

International Business Times UK

Alignment Healthcare Shows Rising Price Performance With Jump To 85 RS Rating

Alignment Healthcare Shows Rising Price Performance With Jump To 85 RS Rating

Alignment Healthcare sees its Relative Strength Rating enter the 80-plus level.

Investors Business Daily

Alignment Healthcare Hits 54th 52-Week High: Does It Have What It Takes to Keep Winning?

Alignment Healthcare Hits 54th 52-Week High: Does It Have What It Takes to Keep Winning?

Alignment Healthcare was among only seven Nasdaq stocks to hit a 52-week high Tuesday. With the S&P 500 on the precipice of a bear market, it’s hard to imagine ALHC maintains momentum. Here’s why it could.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Insights into HealthEquity's Upcoming Earnings

HealthEquity (NASDAQ:HQY) is preparing to release its quarterly earnings on Monday, 2024-12-09. Here's a brief overview of what investors should keep in mind before the announcement.

4 Analysts Have This To Say About Alignment Healthcare

Throughout the last three months, 4 analysts have evaluated Alignment Healthcare (NASDAQ:ALHC), offering a diverse set of opinions from bullish to bearish.

Medicare Advantage: Kroger Teams Up With Soda Health

The list of Medicare Advantage plan partnerships continues to grow with the latest offering from Kroger and Soda Health.

Where Alignment Healthcare Stands With Analysts

Over the past 3 months, 4 analysts have published their opinion on Alignment Healthcare (NASDAQ:ALHC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

inkl

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022

Expert Ratings for Alignment Healthcare

Expert Ratings for Alignment Healthcare

Analysts have provided the following ratings for Alignment Healthcare (NASDAQ:ALHC) within the last quarter:

Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2022

Alignment Healthcare's Return On Capital Employed Insights

Alignment Healthcare's Return On Capital Employed Insights

Alignment Healthcare (NASDAQ:ALHC) brought in sales totaling $298.27 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 4.4%, resulting in a loss of $47.83 million.

What 4 Analyst Ratings Have To Say About Alignment Healthcare

What 4 Analyst Ratings Have To Say About Alignment Healthcare

Alignment Healthcare (NASDAQ:ALHC) has observed the following analyst ratings within the last quarter:

People

129,945 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Medicare Advantage

Cardinal Health

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play